Late effects of treatment for wilms tumor.

Full Abstract

Advancements in surgery, radiotherapy, and chemotherapy have greatly improved the cures rates for children with Wilms tumor. However, a number of therapy-related late effects have been observed in long-term survivors. Generally, late complications are a consequence of treatment type and intensity; the use of radiotherapy and anthracyclines increases the risk of these complications. This commentary highlights some clinically significant late sequelae-musculoskeletal effects, cardiac toxicity, reproductive problems, renal dysfunction, and the development of second malignant neoplasms. Careful medical and epidemiological monitoring of survivors can provide critical information to further optimize therapy while minimizing long-term sequelae.

Author information

Author/s: Wright, Karen D (KD); Green, Daniel M (DM); Daw, Najat C (NC);

Affiliation: Department of Oncology, St. Jude Children's Research Hospital, Memphis, TN 38105-3678, USA. karen.wright(-atsign-)stjude.org

Journal and publication information

Publication Type: Journal Article; Review

Journal: Pediatric hematology and oncology (Pediatr Hematol Oncol), published in England. (Language: eng)

Reference: 2009-Sep; vol 26 (issue 6) : pp 407-13

Dates: Created 2009/08/06; Completed 2009/10/27;

PMID: 19657990, status: MEDLINE (last retrieval date: 10/27/2009, IMS Date: )

Sourced from the National Library of Medicine. Abstract text and other information may be subject to copyright.

External Links for this article
(including full text providers, if available):

Click Electronic Full-text Provider Links to see options for finding the electronic full text links to this article. Note there may be a subscription or fee required for access to the full text. See our FAQ for information on finding FREE full text articles.

This article may also be located in paper journal collections available in many libraries. Use the Journal and Publication Information above to find the full article.